• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC. MILOOP LENS FRAGMENTATION DEVICE; OPHTHALMIC HOOK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC. MILOOP LENS FRAGMENTATION DEVICE; OPHTHALMIC HOOK Back to Search Results
Model Number FG-11881
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Vitreous Loss (2142); Capsular Bag Tear (2639); Vitrectomy (2643)
Event Date 03/26/2019
Event Type  Injury  
Manufacturer Narrative
The device was discarded by the user facility and is not available for evaluation.The device history records were reviewed for this manufacturing lot and there were no discrepancies or unusual findings that relate to the reported event.Based on the information reviewed, there is no evidence to indicate the presence of a potential quality issue with respect to manufacturing, design, or labeling.The relationship between the event and the device is unknown.Capsular bag damage and vitreous loss are inherent risks of cataract surgery.Manufacturer's reference #: (b)(4).
 
Event Description
A (b)(6) female patient underwent cataract surgery in her right eye on (b)(6) 2019 where the miloop device was used to section the cataractous lens into quadrants.The case appeared typical through phacoemulsification, including the first lens sectioning, lens rotation with a drysdale nucleus manipulator (storz), and the second lens sectioning.After sectioning the second lens quadrant, a small capsular tear was observed when the miloop was removed from the eye.After phacoemulsification, a posterior capsular tear occurred parallel to the primary incision.Although the degree of vitreous loss was limited, an anterior vitrectomy was performed and a sulcus-fixated intraocular lens was implanted.The patient was reported as doing well at the one day postoperative visit.At the one week visit, there was some residual corneal edema and the patient's best corrected visual acuity (bcva) was 20/30 (no baseline provided); the patient reports feeling fine and happy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MILOOP LENS FRAGMENTATION DEVICE
Type of Device
OPHTHALMIC HOOK
Manufacturer (Section D)
CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC.
8748 technology way
reno NV 89521
Manufacturer (Section G)
CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC.
8748 technology way
reno NV 89521
Manufacturer Contact
jane demkovich
8748 technology way
reno, NV 89521
7754731014
MDR Report Key8530130
MDR Text Key142462734
Report Number3012123033-2019-00004
Device Sequence Number1
Product Code HNQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/18/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/09/2021
Device Model NumberFG-11881
Device Lot NumberFG20180510-20
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/26/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/11/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-